home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences

Search

 
  IBC's Antimicrobial & Anti-Viral Drug Discovery  
  May 09, 2001

Pharmacology and Toxicology

 
     
  IBC USA Conferences, Inc., Seaport Hotel * Boston, MA
August 13-14, 2001


IBC's gathering of leading researchers in the field of Antimicrobial and Anti-Viral drug discovery will present their recent findings on:

* Proven New Methods to Target Selections and Validations
* Real-Time Assessment of Microbial Infections Using In vivo Biophotonic Imaging
* Ground-Breaking Strategies to Treat HCV Infection
* Genome Sequencing of Streptococcus Pyogenes - Potential Development of Novel Vaccines
* Hear a Global Perspective on the Antibiotic Resistance Crisis from:
Clifton E. Barry, III, Ph.D., Tuberculosis Research Section, NIH
William H. Jarvis, M.D., Center for Disease Control & Prevention
* Critical Updates on Cidecin, Ertapenem, Oritavancin, Anti-HIV Inhibitors, Zadaxin, and Influenza.
 
 
Organized by: IBC USA Conferences, Inc.
 
Deadline for Abstracts: -
 
Registration: Five Easy Ways to Register!
Phone (508) 616-5550
Fax (508) 616-5522
E-mail reg@ibcusa.com
Online www.lifesciencesinfo.com/2647
Mail IBC USA Conferences, Inc.
One Research Drive, Suite 400A
Westborough, MA 01581-5195
E-mail: jprudhomme@ibcusa.com
 
  Posted by:   James G. Prudhomme  
Host: 209.6.93.46
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2001 HUM-MOLGEN. All rights reserved. Liability and Copyright.